Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients

I. Gross, K.M. Trentino, A. Andreescu, R. Pierson, R.A. Maietta, Shannon Farmer

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    © AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p
    Original languageEnglish
    Pages (from-to)327-332
    JournalONCOLOGIST
    Volume21
    Issue number3
    Publication statusPublished - 2016

    Fingerprint

    Anemia
    Inpatients
    Outpatients
    Hematinics
    Hospital Costs
    Observational Studies
    Neoplasms
    Retrospective Studies
    Population

    Cite this

    @article{59a837c87a8e466ea52dcabf5ca3a479,
    title = "Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients",
    abstract = "{\circledC} AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9{\%} in 2008 to 1.1{\%} in 2013 (p",
    author = "I. Gross and K.M. Trentino and A. Andreescu and R. Pierson and R.A. Maietta and Shannon Farmer",
    year = "2016",
    language = "English",
    volume = "21",
    pages = "327--332",
    journal = "ONCOLOGIST",
    issn = "1083-7159",
    publisher = "Alphamed Press",
    number = "3",

    }

    Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. / Gross, I.; Trentino, K.M.; Andreescu, A.; Pierson, R.; Maietta, R.A.; Farmer, Shannon.

    In: ONCOLOGIST, Vol. 21, No. 3, 2016, p. 327-332.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients

    AU - Gross, I.

    AU - Trentino, K.M.

    AU - Andreescu, A.

    AU - Pierson, R.

    AU - Maietta, R.A.

    AU - Farmer, Shannon

    PY - 2016

    Y1 - 2016

    N2 - © AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p

    AB - © AlphaMed Press 2016. Background. Patient blood management (PBM) programs are associated with reduced transfusion usage, reduced hospital costs, and improved patient outcomes.The application of PBM principles in patients with malignant disease might achieve similar results. However, this population presents unique challenges. The aim of the present study was to investigate the impact of a PBM program on blood usage and patient outcomes in cancer patients, particularly in the setting of restricted use of erythropoiesis-stimulating agents (ESAs). Materials and Methods. A retrospective observational study was performed of patients admitted with a primary diagnosis of malignancy treated at Eastern Maine Medical Center as inpatients or outpatients, or both, from January 2008 through July 2013. Results. The proportion of inpatients and outpatients receiving ESAs decreased from 2.9% in 2008 to 1.1% in 2013 (p

    M3 - Article

    VL - 21

    SP - 327

    EP - 332

    JO - ONCOLOGIST

    JF - ONCOLOGIST

    SN - 1083-7159

    IS - 3

    ER -